1. Booster Dose of SARS-CoV-2 mRNA Vaccine in Kidney Transplanted Patients Induces Wuhan-Hu-1 Specific Neutralizing Antibodies and T Cell Activation but Lower Response against Omicron Variant.
- Author
-
Del Mastro, Andrea, Picascia, Stefania, D'Apice, Luciana, Trovato, Maria, Barba, Pasquale, Di Biase, Immacolata, Di Biase, Sebastiano, Laccetti, Marco, Belli, Antonello, Amato, Gerardino, Di Muro, Potito, Credendino, Olga, Picardi, Alessandra, De Berardinis, Piergiuseppe, Del Pozzo, Giovanna, and Gianfrani, Carmen
- Subjects
SARS-CoV-2 Omicron variant ,BOOSTER vaccines ,COVID-19 vaccines ,T cells ,IMMUNOGLOBULINS ,KIDNEY transplantation ,HUMORAL immunity ,T cell receptors - Abstract
Kidney transplanted recipients (KTR) are at high risk of severe SARS-CoV-2 infection due to immunosuppressive therapy. Although several studies reported antibody production in KTR after vaccination, data related to immunity to the Omicron (B.1.1.529) variant are sparse. Herein, we analyzed anti-SARS-CoV-2 immune response in seven KTR and eight healthy controls after the second and third dose of the mRNA vaccine (BNT162b2). A significant increase in neutralizing antibody (nAb) titers were detected against pseudoviruses expressing the Wuhan-Hu-1 spike (S) protein after the third dose in both groups, although nAbs in KTR were lower than controls. nAbs against pseudoviruses expressing the Omicron S protein were low in both groups, with no increase after the 3rd dose in KTR. Reactivity of CD4
+ T cells after boosting was observed when cells were challenged with Wuhan-Hu-1 S peptides, while Omicron S peptides were less effective in both groups. IFN-γ production was detected in KTR in response to ancestral S peptides, confirming antigen-specific T cell activation. Our study demonstrates that the 3rd mRNA dose induces T cell response against Wuhan-Hu-1 spike peptides in KTR, and an increment in the humoral immunity. Instead, humoral and cellular immunity to Omicron variant immunogenic peptides were low in both KTR and healthy vaccinated subjects. [ABSTRACT FROM AUTHOR]- Published
- 2023
- Full Text
- View/download PDF